Crohn's Disease Clinical Trials

Trials for someone you care about with crohn's disease.

Digestive Health

Recruiting Drug Device Behavioral Older adults Healthy volunteers

23 trials

Comparing 3 approaches for Crohn's disease

Explore this study →

Sites in Edmonton, London and 5 more cities

Official title: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Crohn's Disease · Takeda

Testing IV Tulisokibart against a placebo for Crohn's disease

Explore this study →

Sites in London, Montreal and 13 more cities

RecruitingPHASE3

Official title: A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Crohn's Disease · Merck Sharp & Dohme LLC

Comparing Mirikizumab - with LY4395089 for crohn disease

Explore this study →

Sites in Lethbridge, London and 1 more city

RecruitingPHASE2

Official title: A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Crohn Disease · Eli Lilly and Company

Get them matched to the best-fit trials

Answer a few questions and we'll find the closest matches for crohn's disease.

Comparing 9 approaches for Crohn's disease (CD)

Explore this study →

Sites in Edmonton, London and 2 more cities

RecruitingPHASE3

Official title: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Crohn's Disease (CD) · Takeda

Testing Anti-TNF therapy for crohn disease

Explore this study →

Sites in Edmonton, London and 2 more cities

RecruitingPHASE4

Official title: Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Crohn Disease · Connecticut Children's Medical Center

Testing Vedolizumab against a placebo for Crohn's disease

Explore this study →

Sites in Barrie, Calgary and 7 more cities

RecruitingPHASE3

Official title: A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Crohn's Disease · Takeda

Comparing 4 approaches for Crohn's disease

Explore this study →

Sites in London, Montreal and 4 more cities

RecruitingPHASE2

Official title: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Takeda

Comparing KleanLyte with Bi-PegLyte for crohn disease

Explore this study →

One site, in Winnipeg

RecruitingPHASE4

Official title: Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Crohn Disease · University of Manitoba

Comparing 6 approaches for Crohn's disease

Explore this study →

Sites in Halifax, Montreal and 1 more city

RecruitingPHASE3

Official title: Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Crohn's Disease · AbbVie

Comparing 7 approaches for Crohn's disease

Explore this study →

Sites in Edmonton, Calgary and 5 more cities

RecruitingPHASE2

Official title: Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's Disease · AbbVie

Testing SAR441566 against a placebo for Crohn's disease

Explore this study →

Sites in Calgary, Montreal and 1 more city

RecruitingPHASE2

Official title: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Crohn's Disease · Sanofi

Testing Afimkibart against a placebo for moderately to severely active crohns disease

Explore this study →

Sites in Edmonton, Trois-Rivières and 1 more city

RecruitingPHASE3

Official title: A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease · Hoffmann-La Roche

Testing Afimkibart against a placebo for moderately to severely active crohns disease

Explore this study →

Sites in London, Barrie and 3 more cities

RecruitingPHASE3

Official title: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease · Hoffmann-La Roche

Testing Mirikizumab for crohn disease

Explore this study →

Sites in London, Scarborough Village and 1 more city

RecruitingPHASE4

Official title: Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Crohn Disease · Alimentiv Inc.

Testing Duvakitug against a placebo for Crohn's disease

Explore this study →

Sites in Brampton, Edmonton and 5 more cities

RecruitingPHASE3

Official title: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Sanofi

Testing Duvakitug against a placebo for Crohn's disease

Explore this study →

Sites in Hamilton and Toronto

RecruitingPHASE3

Official title: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Sanofi

Comparing Guselkumab with Risankizumab for crohn disease

Explore this study →

Sites in Montreal, Edmonton and 5 more cities

RecruitingPHASE3

Official title: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Comparing 15 approaches for Crohn's disease

Explore this study →

Sites in Calgary, Edmonton and 2 more cities

RecruitingPHASE3

Official title: A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · AbbVie

Comparing Tirzepatide with Mirikizumab for Crohn's disease

Explore this study →

Sites in London, Vancouver and 3 more cities

RecruitingPHASE3

Official title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease · Eli Lilly and Company

Comparing 3 approaches for Crohn's disease

Explore this study →

Sites in Halifax, London and 2 more cities

RecruitingPHASE3

Official title: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Crohn's Disease · Eli Lilly and Company

Comparing 5 approaches for Crohn's disease

Explore this study →

Sites in Halifax, London and 1 more city

RecruitingPHASE3

Official title: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Janssen Research & Development, LLC

Comparing JNJ-78934804 with Guselkumab for crohn disease

Explore this study →

Sites in Edmonton, Montreal and 5 more cities

RecruitingPHASE3

Official title: A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Testing Icotrokinra against a placebo for crohn disease

Explore this study →

Sites in Barrie, Edmonton and 6 more cities

RecruitingPHASE2

Official title: A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Looking for the closest fit?

Get matched →

Get notified when a matching trial opens

We'll watch for Crohn's Disease trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.